메뉴 건너뛰기




Volumn 8, Issue 3, 2011, Pages 488-502

Prevention of Cardioembolic Stroke

Author keywords

Anti coagulation; Atrial fibrillation; Cardiac; Cardioembolic stroke; Myocardial infarction; Stroke

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; AMIODARONE; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; APIXABAN; ARH 067637; AZD 0837; BLOOD CLOTTING INHIBITOR; CLARITHROMYCIN; CLOPIDOGREL; DABIGATRAN; EDOXABAN; KETOCONAZOLE; PLACEBO; PRADAXA TM; QUINIDINE; RIVAROXABAN; TECARFARIN; THROMBIN INHIBITOR; UNCLASSIFIED DRUG; VERAPAMIL; WARFARIN; XIMELAGATRAN;

EID: 79960849978     PISSN: 19337213     EISSN: 18787479     Source Type: Journal    
DOI: 10.1007/s13311-011-0048-y     Document Type: Review
Times cited : (32)

References (138)
  • 1
    • 0024380805 scopus 로고
    • Cardiogenic brain embolism. The second report of the Cerebral Embolism Task Force
    • Asinger RW, Dyken ML, Fisher M. Cardiogenic brain embolism. The second report of the Cerebral Embolism Task Force. Arch Neurol 1989; 46: 727-743.
    • (1989) Arch Neurol , vol.46 , pp. 727-743
    • Asinger, R.W.1    Dyken, M.L.2    Fisher, M.3
  • 2
    • 0025764541 scopus 로고
    • Cardiac sources of embolism and cerebral infarction - clinical consequences and vascular concomitants: the Lausanne Stroke Registry
    • Bogousslavsky J, Cachin C, Regli F, et al. Cardiac sources of embolism and cerebral infarction - clinical consequences and vascular concomitants: the Lausanne Stroke Registry. Neurology 1991; 41: 855-859.
    • (1991) Neurology , vol.41 , pp. 855-859
    • Bogousslavsky, J.1    Cachin, C.2    Regli, F.3
  • 3
    • 79960873121 scopus 로고    scopus 로고
    • Cardioembolic stroke
    • J. H. Noseworthy (Ed.), New York: Martin Dunitz
    • Sila CA. Cardioembolic stroke. In: Noseworthy JH, ed. Neurological therapeutics: principles and practice. New York: Martin Dunitz; 2003: 450-457.
    • (2003) Neurological Therapeutics: Principles and Practice , pp. 450-457
    • Sila, C.A.1
  • 4
    • 0041851005 scopus 로고    scopus 로고
    • Cardioembolic stroke: an update
    • Ferro JM. Cardioembolic stroke: an update. Lancet Neurol 2003; 2: 177-188.
    • (2003) Lancet Neurol , vol.2 , pp. 177-188
    • Ferro, J.M.1
  • 5
    • 0023190659 scopus 로고
    • Can embolic stroke be diagnosed on the basis of neurologic clinical criteria?
    • Ramirez-Lassepas M, Cipolle RJ, Bjork RJ, et al. Can embolic stroke be diagnosed on the basis of neurologic clinical criteria? Arch Neurol 1987; 44: 87-89.
    • (1987) Arch Neurol , vol.44 , pp. 87-89
    • Ramirez-Lassepas, M.1    Cipolle, R.J.2    Bjork, R.J.3
  • 6
    • 0024421769 scopus 로고
    • Intracranial branch atheromatous disease: a neglected, understudied, and underused concept
    • Caplan LR. Intracranial branch atheromatous disease: a neglected, understudied, and underused concept. Neurology 1989; 39: 1246-1250.
    • (1989) Neurology , vol.39 , pp. 1246-1250
    • Caplan, L.R.1
  • 7
    • 0026829557 scopus 로고
    • Cardioembolic stroke: topography and pathogenesis
    • Helgason CM. Cardioembolic stroke: topography and pathogenesis. Cerebrovasc Brain Metab Rev 1992; 4: 28-58.
    • (1992) Cerebrovasc Brain Metab Rev , vol.4 , pp. 28-58
    • Helgason, C.M.1
  • 8
    • 0026567815 scopus 로고
    • Spectacular shrinking deficit" - rapid recovery from a major hemispheric syndrome by migration of an embolus
    • Minematsu K, Yamaguchi T, Omae T. "Spectacular shrinking deficit" - rapid recovery from a major hemispheric syndrome by migration of an embolus. Neurology 1992; 42: 157-162.
    • (1992) Neurology , vol.42 , pp. 157-162
    • Minematsu, K.1    Yamaguchi, T.2    Omae, T.3
  • 9
    • 41249092747 scopus 로고    scopus 로고
    • Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Dise
    • Adams HP Jr., del Zoppo G, Alberts MJ, et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Circulation 2007; 115: e478-e534.
    • (2007) Circulation , vol.115
    • Adams Jr., H.P.1    del Zoppo, G.2    Alberts, M.J.3
  • 10
    • 78149299464 scopus 로고    scopus 로고
    • Prevalence and predictors of paroxysmal atrial fibrillation on Holter monitor in patients with stroke or transient ischemic attack
    • Alhadramy O, Jeerakathil TJ, Majumdar SR, et al. Prevalence and predictors of paroxysmal atrial fibrillation on Holter monitor in patients with stroke or transient ischemic attack. Stroke 2010; 41: 2596-2600.
    • (2010) Stroke , vol.41 , pp. 2596-2600
    • Alhadramy, O.1    Jeerakathil, T.J.2    Majumdar, S.R.3
  • 11
    • 78650420190 scopus 로고    scopus 로고
    • Enhanced detection of paroxysmal atrial fibrillation by early and prolonged continuous holter monitoring in patients with cerebral ischemia presenting in sinus rhythm
    • Stahrenberg R, Weber-Kruger M, Seegers J, et al. Enhanced detection of paroxysmal atrial fibrillation by early and prolonged continuous holter monitoring in patients with cerebral ischemia presenting in sinus rhythm. Stroke 2010; 41: 2884-2888.
    • (2010) Stroke , vol.41 , pp. 2884-2888
    • Stahrenberg, R.1    Weber-Kruger, M.2    Seegers, J.3
  • 12
    • 78650366574 scopus 로고    scopus 로고
    • Testing for inherited thrombophilias in arterial stroke: can it cause more harm than good?
    • Morris JG, Singh S, Fisher M. Testing for inherited thrombophilias in arterial stroke: can it cause more harm than good? Stroke 2010; 41: 2985-2990.
    • (2010) Stroke , vol.41 , pp. 2985-2990
    • Morris, J.G.1    Singh, S.2    Fisher, M.3
  • 13
    • 33645084820 scopus 로고    scopus 로고
    • Therapeutic strategies after examination by transesophageal echocardiography in 503 patients with ischemic stroke
    • Harloff A, Handke M, Reinhard M, Geibel A, Hetzel A. Therapeutic strategies after examination by transesophageal echocardiography in 503 patients with ischemic stroke. Stroke 2006; 37: 859-864.
    • (2006) Stroke , vol.37 , pp. 859-864
    • Harloff, A.1    Handke, M.2    Reinhard, M.3    Geibel, A.4    Hetzel, A.5
  • 14
    • 34347231277 scopus 로고    scopus 로고
    • ACCF/ASE/ACEP/ASNC/SCAI/SCCT/SCMR 2007 appropriateness criteria for transthoracic and transesophageal echocardiography: a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group, American Society of Echocardiography, American College of Emergency Physicians, American Society of Nuclear Cardiology
    • Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and the Society for Cardiovascular Magnetic Resonance endorsed by the American College of Chest Physicians and the Society of Critical Care Medicine
    • Douglas PS, Khandheria B, Stainback RF, et al. ACCF/ASE/ACEP/ASNC/SCAI/SCCT/SCMR 2007 appropriateness criteria for transthoracic and transesophageal echocardiography: a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group, American Society of Echocardiography, American College of Emergency Physicians, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and the Society for Cardiovascular Magnetic Resonance endorsed by the American College of Chest Physicians and the Society of Critical Care Medicine. J Am Coll Cardiol 2007; 50: 187-204.
    • (2007) J Am Coll Cardiol , vol.50 , pp. 187-204
    • Douglas, P.S.1    Khandheria, B.2    Stainback, R.F.3
  • 15
    • 33845482262 scopus 로고    scopus 로고
    • Transesophageal echocardiography in patients with cryptogenic stroke: does it alter their management? A 3-year retrospective study in a single non-referral centre
    • Walpot J, Pasteuning WH, Hoevenaar M, et al. Transesophageal echocardiography in patients with cryptogenic stroke: does it alter their management? A 3-year retrospective study in a single non-referral centre. Acta Clin Belg 2006; 61: 243-248.
    • (2006) Acta Clin Belg , vol.61 , pp. 243-248
    • Walpot, J.1    Pasteuning, W.H.2    Hoevenaar, M.3
  • 16
    • 41549133986 scopus 로고    scopus 로고
    • Therapeutic implications of transesophageal echocardiography after transthoracic echocardiography on acute stroke patients
    • de Abreu TT, Mateus S, Carreteiro C, Correia J. Therapeutic implications of transesophageal echocardiography after transthoracic echocardiography on acute stroke patients. Vasc Health Risk Manag 2008; 4: 167-172.
    • (2008) Vasc Health Risk Manag , vol.4 , pp. 167-172
    • de Abreu, T.T.1    Mateus, S.2    Carreteiro, C.3    Correia, J.4
  • 17
    • 0028079933 scopus 로고
    • Incidence of transcranial Doppler-detected cerebral microemboli in patients referred for echocardiography
    • Tong DC, Bolger A, Albers GW. Incidence of transcranial Doppler-detected cerebral microemboli in patients referred for echocardiography. Stroke 1994; 25: 2138-2141.
    • (1994) Stroke , vol.25 , pp. 2138-2141
    • Tong, D.C.1    Bolger, A.2    Albers, G.W.3
  • 18
    • 0020629850 scopus 로고
    • Cerebral embolism in the Michael Reese Stroke Registry
    • Caplan LR, Hier DB, D'Cruz I. Cerebral embolism in the Michael Reese Stroke Registry. Stroke 1983; 14: 530-536.
    • (1983) Stroke , vol.14 , pp. 530-536
    • Caplan, L.R.1    Hier, D.B.2    D'Cruz, I.3
  • 19
    • 0032763980 scopus 로고    scopus 로고
    • Early differentiation of cardioembolic from atherothrombotic cerebral infarction: a multivariate analysis
    • Arboix A, Oliveres M, Massons J, Pujades R, Garcia-Eroles L. Early differentiation of cardioembolic from atherothrombotic cerebral infarction: a multivariate analysis. Eur J Neurol 1999; 6: 677-683.
    • (1999) Eur J Neurol , vol.6 , pp. 677-683
    • Arboix, A.1    Oliveres, M.2    Massons, J.3    Pujades, R.4    Garcia-Eroles, L.5
  • 20
    • 0033868675 scopus 로고    scopus 로고
    • Posterior circulation ischemia: then, now, and tomorrow. The Thomas Willis Lecture-2000
    • Caplan L. Posterior circulation ischemia: then, now, and tomorrow. The Thomas Willis Lecture-2000. Stroke 2000; 31: 2011-2023.
    • (2000) Stroke , vol.31 , pp. 2011-2023
    • Caplan, L.1
  • 21
    • 0027249378 scopus 로고
    • The etiology of posterior circulation infarcts: a prospective study using magnetic resonance imaging and magnetic resonance angiography
    • Bogousslavsky J, Regli F, Maeder P, Meuli R, Nader J. The etiology of posterior circulation infarcts: a prospective study using magnetic resonance imaging and magnetic resonance angiography. Neurology 1993; 43: 1528-1533.
    • (1993) Neurology , vol.43 , pp. 1528-1533
    • Bogousslavsky, J.1    Regli, F.2    Maeder, P.3    Meuli, R.4    Nader, J.5
  • 22
    • 4444269014 scopus 로고    scopus 로고
    • New England Medical Center Posterior Circulation registry
    • Caplan LR, Wityk RJ, Glass TA, et al. New England Medical Center Posterior Circulation registry. Ann Neurol 2004; 56: 389-398.
    • (2004) Ann Neurol , vol.56 , pp. 389-398
    • Caplan, L.R.1    Wityk, R.J.2    Glass, T.A.3
  • 23
    • 0036190118 scopus 로고    scopus 로고
    • Outcome at 30 days in the New England Medical Center Posterior Circulation Registry
    • Glass TA, Hennessey PM, Pazdera L, et al. Outcome at 30 days in the New England Medical Center Posterior Circulation Registry. Arch Neurol 2002; 59: 369-376.
    • (2002) Arch Neurol , vol.59 , pp. 369-376
    • Glass, T.A.1    Hennessey, P.M.2    Pazdera, L.3
  • 25
    • 0023148111 scopus 로고
    • Clinical features and mechanism of occipital infarction
    • Pessin MS, Lathi ES, Cohen MB, et al. Clinical features and mechanism of occipital infarction. Ann Neurol 1987; 21: 290-299.
    • (1987) Ann Neurol , vol.21 , pp. 290-299
    • Pessin, M.S.1    Lathi, E.S.2    Cohen, M.B.3
  • 26
    • 0033055723 scopus 로고    scopus 로고
    • Posterior cerebral artery territory infarcts in the New England Medical Center Posterior Circulation Registry
    • Yamamoto Y, Georgiadis AL, Chang HM, Caplan LR. Posterior cerebral artery territory infarcts in the New England Medical Center Posterior Circulation Registry. Arch Neurol 1999; 56: 824-832.
    • (1999) Arch Neurol , vol.56 , pp. 824-832
    • Yamamoto, Y.1    Georgiadis, A.L.2    Chang, H.M.3    Caplan, L.R.4
  • 27
    • 0027514354 scopus 로고
    • Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment
    • Adams HP Jr., Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993; 24: 35-41.
    • (1993) Stroke , vol.24 , pp. 35-41
    • Adams Jr., H.P.1    Bendixen, B.H.2    Kappelle, L.J.3
  • 28
    • 65449189576 scopus 로고    scopus 로고
    • Intermittent atrial fibrillation may account for a large proportion of otherwise cryptogenic stroke: a study of 30-day cardiac event monitors
    • Elijovich L, Josephson SA, Fung GL, Smith WS. Intermittent atrial fibrillation may account for a large proportion of otherwise cryptogenic stroke: a study of 30-day cardiac event monitors. J Stroke Cerebrovasc Dis 2009; 18: 185-189.
    • (2009) J Stroke Cerebrovasc Dis , vol.18 , pp. 185-189
    • Elijovich, L.1    Josephson, S.A.2    Fung, G.L.3    Smith, W.S.4
  • 29
    • 58149269939 scopus 로고    scopus 로고
    • Atrial fibrillation detected by mobile cardiac outpatient telemetry in cryptogenic TIA or stroke
    • Tayal AH, Tian M, Kelly KM, et al. Atrial fibrillation detected by mobile cardiac outpatient telemetry in cryptogenic TIA or stroke. Neurology 2008; 71: 1696-1701.
    • (2008) Neurology , vol.71 , pp. 1696-1701
    • Tayal, A.H.1    Tian, M.2    Kelly, K.M.3
  • 30
    • 77952990457 scopus 로고    scopus 로고
    • Detection of paroxysmal atrial fibrillation with transtelephonic EKG in TIA or stroke patients
    • Gaillard N, Deltour S, Vilotijevic B, et al. Detection of paroxysmal atrial fibrillation with transtelephonic EKG in TIA or stroke patients. Neurology 2010; 74: 1666-1670.
    • (2010) Neurology , vol.74 , pp. 1666-1670
    • Gaillard, N.1    Deltour, S.2    Vilotijevic, B.3
  • 31
    • 49849084828 scopus 로고    scopus 로고
    • Etiologic diagnosis of ischemic stroke subtypes with plasma biomarkers
    • Montaner J, Perea-Gainza M, Delgado P, et al. Etiologic diagnosis of ischemic stroke subtypes with plasma biomarkers. Stroke 2008; 39: 2280-2287.
    • (2008) Stroke , vol.39 , pp. 2280-2287
    • Montaner, J.1    Perea-Gainza, M.2    Delgado, P.3
  • 32
    • 66149160627 scopus 로고    scopus 로고
    • Plasma brain natriuretic peptide can be a biological marker to distinguish cardioembolic stroke from other stroke types in acute ischemic stroke
    • Shibazaki K, Kimura K, Iguchi Y, Okada Y, Inoue T. Plasma brain natriuretic peptide can be a biological marker to distinguish cardioembolic stroke from other stroke types in acute ischemic stroke. Intern Med 2009; 48: 259-264.
    • (2009) Intern Med , vol.48 , pp. 259-264
    • Shibazaki, K.1    Kimura, K.2    Iguchi, Y.3    Okada, Y.4    Inoue, T.5
  • 33
    • 33747052359 scopus 로고    scopus 로고
    • Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence
    • Miyasaka Y, Barnes ME, Gersh BJ, et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation 2006; 114: 119-125.
    • (2006) Circulation , vol.114 , pp. 119-125
    • Miyasaka, Y.1    Barnes, M.E.2    Gersh, B.J.3
  • 34
    • 33746833635 scopus 로고    scopus 로고
    • ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation - executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines
    • (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation). [Erratum appears in J Am Coll Cardiol 2007;50:562
    • Fuster V, Ryden LE, Cannom DS, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation - executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation). [Erratum appears in J Am Coll Cardiol 2007; 50: 562]. J Am Coll Cardiol 2006; 48: 854-906.
    • (2006) J Am Coll Cardiol , vol.48 , pp. 854-906
    • Fuster, V.1    Ryden, L.E.2    Cannom, D.S.3
  • 35
    • 0028921708 scopus 로고
    • Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications
    • Feinberg WM, Blackshear JL, Laupacis A, Kronmal R, Hart RG. Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. Arch Intern Med 1995; 155: 469-473.
    • (1995) Arch Intern Med , vol.155 , pp. 469-473
    • Feinberg, W.M.1    Blackshear, J.L.2    Laupacis, A.3    Kronmal, R.4    Hart, R.G.5
  • 36
    • 33744945247 scopus 로고    scopus 로고
    • Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial
    • Connolly S, Pogue J, Hart R, et al. Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial. Lancet 2006; 367: 1903-1912.
    • (2006) Lancet , vol.367 , pp. 1903-1912
    • Connolly, S.1    Pogue, J.2    Hart, R.3
  • 37
    • 36248994010 scopus 로고    scopus 로고
    • Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W Substudy
    • Hohnloser SH, Pajitnev D, Pogue J, et al. Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W Substudy. J Am Coll Cardiol 2007; 50: 2156-2161.
    • (2007) J Am Coll Cardiol , vol.50 , pp. 2156-2161
    • Hohnloser, S.H.1    Pajitnev, D.2    Pogue, J.3
  • 38
    • 0035832261 scopus 로고    scopus 로고
    • Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study
    • Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001; 285: 2370-2375.
    • (2001) Jama , vol.285 , pp. 2370-2375
    • Go, A.S.1    Hylek, E.M.2    Phillips, K.A.3
  • 39
    • 0025779484 scopus 로고
    • Atrial fibrillation as an independent risk factor for stroke: the Framingham Study
    • Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991; 22: 983-988.
    • (1991) Stroke , vol.22 , pp. 983-988
    • Wolf, P.A.1    Abbott, R.D.2    Kannel, W.B.3
  • 40
    • 0025241137 scopus 로고
    • The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators
    • The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators
    • The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. N Engl J Med 1990; 323: 1505-1511.
    • (1990) N Engl J Med , vol.323 , pp. 1505-1511
  • 41
    • 0025914693 scopus 로고
    • Stroke Prevention in Atrial Fibrillation Investigators. Stroke Prevention in Atrial Fibrillation Study. Final results
    • Stroke Prevention in Atrial Fibrillation Investigators. Stroke Prevention in Atrial Fibrillation Study. Final results. Circulation 1991; 84: 527-539.
    • (1991) Circulation , vol.84 , pp. 527-539
  • 42
    • 0032557174 scopus 로고    scopus 로고
    • Patients with nonvalvular atrial fibrillation at low risk of stroke during treatment with aspirin: Stroke Prevention in Atrial Fibrillation III Study
    • The SPAF III Writing Committee for the Stroke Prevention in Atrial Fibrillation Investigators
    • The SPAF III Writing Committee for the Stroke Prevention in Atrial Fibrillation Investigators. Patients with nonvalvular atrial fibrillation at low risk of stroke during treatment with aspirin: Stroke Prevention in Atrial Fibrillation III Study. JAMA 1998; 279: 1273-1277.
    • (1998) JAMA , vol.279 , pp. 1273-1277
  • 43
    • 0024543543 scopus 로고
    • Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study
    • Petersen P, Boysen G, Godtfredsen J, Andersen ED, Andersen B. Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study. Lancet 1989; 1: 175-179.
    • (1989) Lancet , vol.1 , pp. 175-179
    • Petersen, P.1    Boysen, G.2    Godtfredsen, J.3    Andersen, E.D.4    Andersen, B.5
  • 44
    • 0025814587 scopus 로고
    • Canadian Atrial Fibrillation Anticoagulation (CAFA) Study
    • Connolly SJ, Laupacis A, Gent M, et al. Canadian Atrial Fibrillation Anticoagulation (CAFA) Study. J Am Coll Cardiol 1991; 18: 349-355.
    • (1991) J Am Coll Cardiol , vol.18 , pp. 349-355
    • Connolly, S.J.1    Laupacis, A.2    Gent, M.3
  • 45
    • 0034725876 scopus 로고    scopus 로고
    • Assessment of three schemes for stratifying stroke risk in patients with nonvalvular atrial fibrillation
    • Pearce LA, Hart RG, Halperin JL. Assessment of three schemes for stratifying stroke risk in patients with nonvalvular atrial fibrillation. Am J Med 2000; 109: 45-51.
    • (2000) Am J Med , vol.109 , pp. 45-51
    • Pearce, L.A.1    Hart, R.G.2    Halperin, J.L.3
  • 46
    • 0035854054 scopus 로고    scopus 로고
    • Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation
    • Gage BF, Waterman AD, Shannon W, et al. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 2001; 285: 2864-2870.
    • (2001) Jama , vol.285 , pp. 2864-2870
    • Gage, B.F.1    Waterman, A.D.2    Shannon, W.3
  • 47
    • 0028244264 scopus 로고
    • Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials
    • Atrial Fibrillation Investigators: Atrial Fibrillation, Aspirin, Anticoagulation Study; Boston Area Anticoagulation Trial for Atrial Fibrillation Study; Canadian Atrial Fibrillation Anticoagulation Study; Stroke Prevention in Atrial Fibrillation Study; Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Study, [Erratum appears in Arch Intern Med 1994; 154: 2254]
    • Atrial Fibrillation Investigators: Atrial Fibrillation, Aspirin, Anticoagulation Study; Boston Area Anticoagulation Trial for Atrial Fibrillation Study; Canadian Atrial Fibrillation Anticoagulation Study; Stroke Prevention in Atrial Fibrillation Study; Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Study. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. [Erratum appears in Arch Intern Med 1994; 154: 2254]. Arch Intern Med 1994; 154: 1449-1457.
    • (1994) Arch Intern Med , vol.154 , pp. 1449-1457
  • 48
    • 0033583748 scopus 로고    scopus 로고
    • Preventing stroke in patients with atrial fibrillation
    • Ezekowitz MD, Levine JA. Preventing stroke in patients with atrial fibrillation. JAMA 1999; 281: 1830-1835.
    • (1999) Jama , vol.281 , pp. 1830-1835
    • Ezekowitz, M.D.1    Levine, J.A.2
  • 49
    • 0031728632 scopus 로고    scopus 로고
    • Antithrombotic therapy in atrial fibrillation
    • Laupacis A, Albers G, Dalen J, et al. Antithrombotic therapy in atrial fibrillation. Chest 1998; 114: 579S-589S.
    • (1998) Chest , vol.114 , pp. 579-589
    • Laupacis, A.1    Albers, G.2    Dalen, J.3
  • 50
    • 34347394385 scopus 로고    scopus 로고
    • Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation
    • Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 2007; 146: 857-867.
    • (2007) Ann Intern Med , vol.146 , pp. 857-867
    • Hart, R.G.1    Pearce, L.A.2    Aguilar, M.I.3
  • 51
    • 0027505093 scopus 로고
    • Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. EAFT (European Atrial Fibrillation Trial) Study Group
    • Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. EAFT (European Atrial Fibrillation Trial) Study Group. Lancet 1993; 342: 1255-1262.
    • (1993) Lancet , vol.342 , pp. 1255-1262
  • 52
    • 0033527355 scopus 로고    scopus 로고
    • Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis
    • Hart RG, Benavente O, McBride R, Pearce LA. Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis. Ann Intern Med 1999; 131: 492-501.
    • (1999) Ann Intern Med , vol.131 , pp. 492-501
    • Hart, R.G.1    Benavente, O.2    McBride, R.3    Pearce, L.A.4
  • 53
    • 33644878356 scopus 로고    scopus 로고
    • Antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks
    • Aguilar M, Hart R. Antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks. Cochrane Database Syst Rev 2005: CD001925.
    • (2005) Cochrane Database Syst Rev
    • Aguilar, M.1    Hart, R.2
  • 54
    • 0031852543 scopus 로고    scopus 로고
    • Fixed minidose warfarin and aspirin alone and in combination vs adjusted-dose warfarin for stroke prevention in atrial fibrillation: Second Copenhagen Atrial Fibrillation, Aspirin, and Anticoagulation Study
    • Gullov AL, Koefoed BG, Petersen P, et al. Fixed minidose warfarin and aspirin alone and in combination vs adjusted-dose warfarin for stroke prevention in atrial fibrillation: Second Copenhagen Atrial Fibrillation, Aspirin, and Anticoagulation Study. Arch Intern Med 1998; 158: 1513-1521.
    • (1998) Arch Intern Med , vol.158 , pp. 1513-1521
    • Gullov, A.L.1    Koefoed, B.G.2    Petersen, P.3
  • 55
    • 0033539341 scopus 로고    scopus 로고
    • Primary prevention of arterial thromboembolism in non-rheumatic atrial fibrillation in primary care: randomised controlled trial comparing two intensities of coumarin with aspirin
    • Hellemons BS, Langenberg M, Lodder J, et al. Primary prevention of arterial thromboembolism in non-rheumatic atrial fibrillation in primary care: randomised controlled trial comparing two intensities of coumarin with aspirin. BMJ 1999; 319: 958-964.
    • (1999) Bmj , vol.319 , pp. 958-964
    • Hellemons, B.S.1    Langenberg, M.2    Lodder, J.3
  • 56
    • 29344473546 scopus 로고    scopus 로고
    • Primary prevention of arterial thromboembolism in the oldest old with atrial fibrillation - a randomized pilot trial comparing adjusted-dose and fixed low-dose coumadin with aspirin
    • Vemmos KN, Tsivgoulis G, Spengos K, et al. Primary prevention of arterial thromboembolism in the oldest old with atrial fibrillation - a randomized pilot trial comparing adjusted-dose and fixed low-dose coumadin with aspirin. Eur J Intern Med 2006; 17: 48-52.
    • (2006) Eur J Intern Med , vol.17 , pp. 48-52
    • Vemmos, K.N.1    Tsivgoulis, G.2    Spengos, K.3
  • 57
    • 43249092279 scopus 로고    scopus 로고
    • The randomized study of efficiency and safety of antithrombotic therapy in nonvalvular atrial fibrillation: warfarin compared with aspirin
    • Hu DY, Zhang HP, Sun YH, Jiang LQ. [The randomized study of efficiency and safety of antithrombotic therapy in nonvalvular atrial fibrillation: warfarin compared with aspirin]. Zhonghua Xin Xue Guan Bing Za Zhi 2006; 34: 295-298.
    • (2006) Zhonghua Xin Xue Guan Bing Za Zhi , vol.34 , pp. 295-298
    • Hu, D.Y.1    Zhang, H.P.2    Sun, Y.H.3    Jiang, L.Q.4
  • 58
    • 33947413877 scopus 로고    scopus 로고
    • A randomised controlled trial of warfarin versus aspirin for stroke prevention in octogenarians with atrial fibrillation (WASPO)
    • Rash A, Downes T, Portner R, et al. A randomised controlled trial of warfarin versus aspirin for stroke prevention in octogenarians with atrial fibrillation (WASPO). Age Ageing 2007; 36: 151-156.
    • (2007) Age Ageing , vol.36 , pp. 151-156
    • Rash, A.1    Downes, T.2    Portner, R.3
  • 59
    • 5644295138 scopus 로고    scopus 로고
    • Comparative effects of antiplatelet, anticoagulant, or combined therapy in patients with valvular and nonvalvular atrial fibrillation: a randomized multicenter study
    • Perez-Gomez F, Alegria E, Berjon J, et al. Comparative effects of antiplatelet, anticoagulant, or combined therapy in patients with valvular and nonvalvular atrial fibrillation: a randomized multicenter study. J Am Coll Cardiol 2004; 44: 1557-1566.
    • (2004) J Am Coll Cardiol , vol.44 , pp. 1557-1566
    • Perez-Gomez, F.1    Alegria, E.2    Berjon, J.3
  • 60
    • 9544248668 scopus 로고    scopus 로고
    • Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial
    • Stroke Prevention in Atrial Fibrillation Investigators
    • Stroke Prevention in Atrial Fibrillation Investigators. Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial. Lancet 1996; 348: 633-638.
    • (1996) Lancet , vol.348 , pp. 633-638
  • 61
    • 4644261801 scopus 로고    scopus 로고
    • Antithrombotic and thrombolytic therapy for ischemic stroke: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
    • Albers GW, Amarenco P, Easton JD, Sacco RL, Teal P. Antithrombotic and thrombolytic therapy for ischemic stroke: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126: 483S-512S.
    • (2004) Chest , vol.126 , pp. 483-512
    • Albers, G.W.1    Amarenco, P.2    Easton, J.D.3    Sacco, R.L.4    Teal, P.5
  • 62
    • 65649145705 scopus 로고    scopus 로고
    • Effect of clopidogrel added to aspirin in patients with atrial fibrillation
    • Connolly SJ, Pogue J, Hart RG, et al. Effect of clopidogrel added to aspirin in patients with atrial fibrillation. N Engl J Med 2009; 360: 2066-2078.
    • (2009) N Engl J Med , vol.360 , pp. 2066-2078
    • Connolly, S.J.1    Pogue, J.2    Hart, R.G.3
  • 63
    • 34547693119 scopus 로고    scopus 로고
    • Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial
    • Mant J, Hobbs FD, Fletcher K, et al. Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial. Lancet 2007; 370: 493-503.
    • (2007) Lancet , vol.370 , pp. 493-503
    • Mant, J.1    Hobbs, F.D.2    Fletcher, K.3
  • 64
    • 69849100157 scopus 로고    scopus 로고
    • The net clinical benefit of warfarin anticoagulation in atrial fibrillation
    • Singer DE, Chang Y, Fang MC, et al. The net clinical benefit of warfarin anticoagulation in atrial fibrillation. Ann Intern Med 2009; 151: 297-305.
    • (2009) Ann Intern Med , vol.151 , pp. 297-305
    • Singer, D.E.1    Chang, Y.2    Fang, M.C.3
  • 65
    • 33947491766 scopus 로고    scopus 로고
    • Secondary stroke prevention with ximelagatran versus warfarin in patients with atrial fibrillation: pooled analysis of SPORTIF III and V clinical trials
    • Akins PT, Feldman HA, Zoble RG, et al. Secondary stroke prevention with ximelagatran versus warfarin in patients with atrial fibrillation: pooled analysis of SPORTIF III and V clinical trials. Stroke 2007; 38: 874-880.
    • (2007) Stroke , vol.38 , pp. 874-880
    • Akins, P.T.1    Feldman, H.A.2    Zoble, R.G.3
  • 66
    • 13444309949 scopus 로고    scopus 로고
    • Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a randomized trial
    • Albers GW, Diener HC, Frison L, et al. Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a randomized trial. JAMA 2005; 293: 690-698.
    • (2005) Jama , vol.293 , pp. 690-698
    • Albers, G.W.1    Diener, H.C.2    Frison, L.3
  • 67
    • 0345414673 scopus 로고    scopus 로고
    • Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial
    • Olsson SB. Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial. Lancet 2003; 362: 1691-1698.
    • (2003) Lancet , vol.362 , pp. 1691-1698
    • Olsson, S.B.1
  • 68
    • 70349306707 scopus 로고    scopus 로고
    • Dabigatran versus warfarin in patients with atrial fibrillation
    • Connolly SJ, Ezekowitz MD, Yusuf S, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009; 361: 1139-1151.
    • (2009) N Engl J Med , vol.361 , pp. 1139-1151
    • Connolly, S.J.1    Ezekowitz, M.D.2    Yusuf, S.3
  • 69
    • 79960878857 scopus 로고    scopus 로고
    • Dabigatran (Pradaxa) [Package Insert]: Boehringer Ingelheim Pharmaceuticals, Inc
    • Dabigatran (Pradaxa) [Package Insert]: Boehringer Ingelheim Pharmaceuticals, Inc.; 2010.
    • (2010)
  • 70
    • 84857103066 scopus 로고    scopus 로고
    • FDA approves Pradaxa to prevent stroke in people with atrial fibrillation
    • Accessed November 10, [online], October 10, 2010. Available at
    • FDA approves Pradaxa to prevent stroke in people with atrial fibrillation. In: FDA News Release [online], October 10, 2010. Available at: http://www. fda. gov/NewsEvents/Newsroom/PressAnnouncements/ucm230241. htm. Accessed November 10, 2010.
    • (2010) In: FDA News Release
  • 71
    • 84857101916 scopus 로고    scopus 로고
    • Risk of intracerebral hemorrhage in patients treated with warfarin
    • Waltham, MA: UpToDate, Inc.; January; Available at, Accessed November 14
    • Freeman WD, Aguilar MI, Weitz J. Risk of intracerebral hemorrhage in patients treated with warfarin. In: UpToDate database. Waltham, MA: UpToDate, Inc.; January 2010; Available at: http://www. uptodate. com/contents/risk-of-intracerebral-hemorrhage-in-patients-treated-with-w arfarin?source=search_result& selectedTitle=1%7E150. Accessed November 14, 2010.
    • (2010) In: UpToDate database
    • Freeman, W.D.1    Aguilar, M.I.2    Weitz, J.3
  • 72
    • 79952301326 scopus 로고    scopus 로고
    • Apixaban in patients with atrial fibrillation
    • Connolly SJ, Eikelboom J, Joyner C, et al. Apixaban in patients with atrial fibrillation. N Engl J Med 2011; 364: 806-817.
    • (2011) N Engl J Med , vol.364 , pp. 806-817
    • Connolly, S.J.1    Eikelboom, J.2    Joyner, C.3
  • 73
    • 70349705645 scopus 로고    scopus 로고
    • The first evaluation of a novel vitamin K antagonist, tecarfarin (ATI-5923), in patients with atrial fibrillation
    • Ellis DJ, Usman MH, Milner PG, Canafax DM, Ezekowitz MD. The first evaluation of a novel vitamin K antagonist, tecarfarin (ATI-5923), in patients with atrial fibrillation. Circulation 2009; 120: 1029-1035.
    • (2009) Circulation , vol.120 , pp. 1029-1035
    • Ellis, D.J.1    Usman, M.H.2    Milner, P.G.3    Canafax, D.M.4    Ezekowitz, M.D.5
  • 74
    • 67650755000 scopus 로고    scopus 로고
    • Contemporary management of atrial fibrillation: update on anticoagulation and invasive management strategies
    • Crandall MA, Bradley DJ, Packer DL, Asirvatham SJ. Contemporary management of atrial fibrillation: update on anticoagulation and invasive management strategies. Mayo Clin Proc 2009; 84: 643-662.
    • (2009) Mayo Clin Proc , vol.84 , pp. 643-662
    • Crandall, M.A.1    Bradley, D.J.2    Packer, D.L.3    Asirvatham, S.J.4
  • 76
    • 84857103332 scopus 로고    scopus 로고
    • Left atrial occlusion search
    • gov [online]. Available at, Accessed November 14
    • Left atrial occlusion" search. ClinicalTrials. gov [online]. Available at: http://clinicaltrials. gov/ct2/results?term=left+atrial+occlusion. Accessed November 14, 2010.
    • (2010) ClinicalTrials
  • 77
    • 56349131353 scopus 로고    scopus 로고
    • Stroke prevention in atrial fibrillation and other major cardiac sources of embolism
    • Freeman WD, Aguilar MI, Weitz J. Stroke prevention in atrial fibrillation and other major cardiac sources of embolism. Neurol Clin 2008; 26: 1129-1160.
    • (2008) Neurol Clin , vol.26 , pp. 1129-1160
    • Freeman, W.D.1    Aguilar, M.I.2    Weitz, J.3
  • 78
    • 0014667477 scopus 로고
    • Working Party on Anticoagulant Therapy in Coronary Thrombosis. Assessment of short-anticoagulant administration after cardiac infarction. Report of the Working Party on Anticoagulant Therapy in Coronary Thrombosis to the Medical Research Council
    • Working Party on Anticoagulant Therapy in Coronary Thrombosis. Assessment of short-anticoagulant administration after cardiac infarction. Report of the Working Party on Anticoagulant Therapy in Coronary Thrombosis to the Medical Research Council. Br Med J 1969; 1: 335-342.
    • (1969) Br Med J , vol.1 , pp. 335-342
  • 79
    • 0015922362 scopus 로고
    • Anticoagulants in acute myocardial infarction. Results of a cooperative clinical trial
    • Anticoagulants in acute myocardial infarction. Results of a cooperative clinical trial. JAMA 1973; 225: 724-729.
    • (1973) JAMA , vol.225 , pp. 724-729
  • 80
    • 0028157098 scopus 로고
    • Effect of long-term oral anticoagulant treatment on mortality and cardiovascular morbidity after myocardial infarction. Anticoagulants in the Secondary Prevention of Events in Coronary Thrombosis (ASPECT) Research Group
    • Effect of long-term oral anticoagulant treatment on mortality and cardiovascular morbidity after myocardial infarction. Anticoagulants in the Secondary Prevention of Events in Coronary Thrombosis (ASPECT) Research Group. Lancet 1994; 343: 499-503.
    • (1994) Lancet , vol.343 , pp. 499-503
  • 81
    • 0031785383 scopus 로고    scopus 로고
    • Antithrombotic agents in coronary artery disease
    • Cairns JA, Theroux P, Lewis HD Jr., et al. Antithrombotic agents in coronary artery disease. Chest 1998; 114: 611S-633S.
    • (1998) Chest , vol.114 , pp. 611-633
    • Cairns, J.A.1    Theroux, P.2    Lewis Jr., H.D.3
  • 82
    • 0015529991 scopus 로고
    • Anticoagulant therapy after acute myocardial infarction. Relation of therapeutic benefit to patient's age, sex, and severity of infarction
    • Drapkin A, Merskey C. Anticoagulant therapy after acute myocardial infarction. Relation of therapeutic benefit to patient's age, sex, and severity of infarction. JAMA 1972; 222: 541-548.
    • (1972) Jama , vol.222 , pp. 541-548
    • Drapkin, A.1    Merskey, C.2
  • 83
    • 0002419956 scopus 로고    scopus 로고
    • Chronic heart failure management
    • E. J. Topol (Ed.), Philadelphia: Lippincott-Raven
    • Young JB. Chronic heart failure management. In: Topol EJ, ed. Comprehensive Cardiovascular Medicine. Philadelphia: Lippincott-Raven; 1998.
    • (1998) Comprehensive Cardiovascular Medicine
    • Young, J.B.1
  • 84
    • 0036515019 scopus 로고    scopus 로고
    • Mechanisms of cardioembolic stroke
    • Di Tullio MR, Homma S. Mechanisms of cardioembolic stroke. Curr Cardiol Rep 2002; 4: 141-148.
    • (2002) Curr Cardiol Rep , vol.4 , pp. 141-148
    • Di Tullio, M.R.1    Homma, S.2
  • 85
    • 41849098159 scopus 로고    scopus 로고
    • Patent foramen ovale and migraine: a quantitative systematic review
    • Schwedt TJ, Demaerschalk BM, Dodick DW. Patent foramen ovale and migraine: a quantitative systematic review. Cephalalgia 2008; 28: 531-540.
    • (2008) Cephalalgia , vol.28 , pp. 531-540
    • Schwedt, T.J.1    Demaerschalk, B.M.2    Dodick, D.W.3
  • 86
    • 22244468721 scopus 로고    scopus 로고
    • Patent foramen ovale closure devices: moving beyond equipoise
    • Maisel WH, Laskey WK. Patent foramen ovale closure devices: moving beyond equipoise. JAMA 2005; 294: 366-369.
    • (2005) Jama , vol.294 , pp. 366-369
    • Maisel, W.H.1    Laskey, W.K.2
  • 87
    • 0037024261 scopus 로고    scopus 로고
    • Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke Study
    • Homma S, Sacco RL, Di Tullio MR, Sciacca RR, Mohr JP. Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke Study. Circulation 2002; 105: 2625-2631.
    • (2002) Circulation , vol.105 , pp. 2625-2631
    • Homma, S.1    Sacco, R.L.2    Di Tullio, M.R.3    Sciacca, R.R.4    Mohr, J.P.5
  • 88
    • 1842528129 scopus 로고    scopus 로고
    • Practice parameter: recurrent stroke with patent foramen ovale and atrial septal aneurysm: report of the Quality Standards Subcommittee of the American Academy of Neurology
    • Messe SR, Silverman IE, Kizer JR, et al. Practice parameter: recurrent stroke with patent foramen ovale and atrial septal aneurysm: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2004; 62: 1042-1050.
    • (2004) Neurology , vol.62 , pp. 1042-1050
    • Messe, S.R.1    Silverman, I.E.2    Kizer, J.R.3
  • 89
    • 84857103640 scopus 로고    scopus 로고
    • Medscape, LLC, Accessed November 10, 2010, [online]; Available at:
    • CLOSURE 1 Trial results. Medscape, LLC [online]; 2010. Available at: http://www. theheart. org/article/1088789. do. Accessed November 10, 2010.
    • (2010) CLOSURE 1 Trial results
  • 90
    • 78650417539 scopus 로고    scopus 로고
    • Study design of the CLOSURE I Trial: a prospective, multicenter, randomized, controlled trial to evaluate the safety and efficacy of the STARFlex septal closure system versus best medical therapy in patients with stroke or transient ischemic attack due to presumed paradoxical embolism through a patent foramen ovale
    • Furlan AJ, Reisman M, Massaro J, et al. Study design of the CLOSURE I Trial: a prospective, multicenter, randomized, controlled trial to evaluate the safety and efficacy of the STARFlex septal closure system versus best medical therapy in patients with stroke or transient ischemic attack due to presumed paradoxical embolism through a patent foramen ovale. Stroke 2010; 41: 2872-2883.
    • (2010) Stroke , vol.41 , pp. 2872-2883
    • Furlan, A.J.1    Reisman, M.2    Massaro, J.3
  • 91
    • 37249013214 scopus 로고    scopus 로고
    • RESPECT PFO Clinical Trial, [online]; 2010. Available at, Accessed November 14
    • RESPECT PFO Clinical Trial. ClinicalTrials. gov [online]; 2010. Available at: http://clinicaltrials. gov/ct2/show/NCT00465270. Accessed November 14, 2010.
    • (2010) ClinicalTrials. gov
  • 92
    • 84857100831 scopus 로고    scopus 로고
    • Patent Foramen Ovale Closure or Anticoagulants Versus Antiplatelet Therapy to Prevent Stroke Recurrence (CLOSE) Trial
    • Accessed November 14, [online]; 2010. Available from
    • Patent Foramen Ovale Closure or Anticoagulants Versus Antiplatelet Therapy to Prevent Stroke Recurrence (CLOSE) Trial. ClinicalTrials. gov [online]; 2010. Available from: http://clinicaltrials. gov/ct2/show/NCT00562289. Accessed November 14, 2010.
    • (2010) ClinicalTrials. gov
  • 93
    • 0028265052 scopus 로고
    • Paradoxical embolism as a cause of ischemic stroke of uncertain etiology. A transcranial Doppler sonographic study
    • Itoh T, Matsumoto M, Handa N, et al. Paradoxical embolism as a cause of ischemic stroke of uncertain etiology. A transcranial Doppler sonographic study. Stroke 1994; 25: 771-775.
    • (1994) Stroke , vol.25 , pp. 771-775
    • Itoh, T.1    Matsumoto, M.2    Handa, N.3
  • 94
    • 74949125286 scopus 로고    scopus 로고
    • Impending paradoxical embolism: systematic review of prognostic factors and treatment
    • Myers PO, Bounameaux H, Panos A, Lerch R, Kalangos A. Impending paradoxical embolism: systematic review of prognostic factors and treatment. Chest 2010; 137: 164-170.
    • (2010) Chest , vol.137 , pp. 164-170
    • Myers, P.O.1    Bounameaux, H.2    Panos, A.3    Lerch, R.4    Kalangos, A.5
  • 95
    • 33749061448 scopus 로고    scopus 로고
    • ACCF/ACR/SCCT/SCMR/ASNC/NASCI/SCAI/SIR 2006 appropriateness criteria for cardiac computed tomography and cardiac magnetic resonance imaging: a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group, American College of Radiology
    • Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, American Society of Nuclear Cardiology, North American Society for Cardiac Imaging, Society for Cardiovascular Angiography and Interventions, and Society of Interventional Radiology
    • Hendel RC, Patel MR, Kramer CM, et al. ACCF/ACR/SCCT/SCMR/ASNC/NASCI/SCAI/SIR 2006 appropriateness criteria for cardiac computed tomography and cardiac magnetic resonance imaging: a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group, American College of Radiology, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, American Society of Nuclear Cardiology, North American Society for Cardiac Imaging, Society for Cardiovascular Angiography and Interventions, and Society of Interventional Radiology. J Am Coll Cardiol 2006; 48: 1475-1497.
    • (2006) J Am Coll Cardiol , vol.48 , pp. 1475-1497
    • Hendel, R.C.1    Patel, M.R.2    Kramer, C.M.3
  • 96
    • 33847098787 scopus 로고    scopus 로고
    • Evaluating cardiac sources of embolic stroke with MRI
    • Rustemli A, Bhatti TK, Wolff SD. Evaluating cardiac sources of embolic stroke with MRI. Echocardiography 2007; 24: 301-308.
    • (2007) Echocardiography , vol.24 , pp. 301-308
    • Rustemli, A.1    Bhatti, T.K.2    Wolff, S.D.3
  • 97
    • 78149359683 scopus 로고    scopus 로고
    • Stroke risk and antithrombotic strategies in atrial fibrillation
    • Medi C, Hankey GJ, Freedman SB. Stroke risk and antithrombotic strategies in atrial fibrillation. Stroke 2010; 41: 2705-2713.
    • (2010) Stroke , vol.41 , pp. 2705-2713
    • Medi, C.1    Hankey, G.J.2    Freedman, S.B.3
  • 100
    • 0032972473 scopus 로고    scopus 로고
    • Prevalence of heart failure and left ventricular dysfunction in the general population; The Rotterdam Study
    • Mosterd A, Hoes AW, de Bruyne MC, et al. Prevalence of heart failure and left ventricular dysfunction in the general population; The Rotterdam Study. Eur Heart J 1999; 20: 447-455.
    • (1999) Eur Heart J , vol.20 , pp. 447-455
    • Mosterd, A.1    Hoes, A.W.2    de Bruyne, M.C.3
  • 101
    • 33745667989 scopus 로고    scopus 로고
    • Ischemic stroke after heart failure: a community-based study
    • Witt BJ, Brown RD Jr., Jacobsen SJ, et al. Ischemic stroke after heart failure: a community-based study. Am Heart J 2006; 152: 102-109.
    • (2006) Am Heart J , vol.152 , pp. 102-109
    • Witt, B.J.1    Brown Jr., R.D.2    Jacobsen, S.J.3
  • 102
    • 1842295207 scopus 로고    scopus 로고
    • Ventricular dysfunction and the risk of stroke after myocardial infarction
    • Loh E, Sutton MS, Wun CC, et al. Ventricular dysfunction and the risk of stroke after myocardial infarction. N Engl J Med 1997; 336: 251-257.
    • (1997) N Engl J Med , vol.336 , pp. 251-257
    • Loh, E.1    Sutton, M.S.2    Wun, C.C.3
  • 103
    • 0001566516 scopus 로고
    • The effect of dicumarol upon the mortality and incidence of thromboembolic complications in congestive heart failure
    • Anderson GM, Hull E. The effect of dicumarol upon the mortality and incidence of thromboembolic complications in congestive heart failure. Am Heart J 1950; 39: 697-702.
    • (1950) Am Heart J , vol.39 , pp. 697-702
    • Anderson, G.M.1    Hull, E.2
  • 104
    • 0000315462 scopus 로고
    • A study of the beneficial effects of anticoagulant therapy in congestive heart failure
    • Griffith GC, Stragnell R, Levinson DC, Moore FJ, Ware AG. A study of the beneficial effects of anticoagulant therapy in congestive heart failure. Ann Intern Med 1952; 37: 867-887.
    • (1952) Ann Intern Med , vol.37 , pp. 867-887
    • Griffith, G.C.1    Stragnell, R.2    Levinson, D.C.3    Moore, F.J.4    Ware, A.G.5
  • 105
    • 0001459066 scopus 로고
    • Dicumarol prophylaxis of thromboembolic disease in congestive heart failure
    • Harvey WP, Finch CA. Dicumarol prophylaxis of thromboembolic disease in congestive heart failure. N Engl J Med 1950; 242: 208-211.
    • (1950) N Engl J Med , vol.242 , pp. 208-211
    • Harvey, W.P.1    Finch, C.A.2
  • 106
    • 0033982009 scopus 로고    scopus 로고
    • Cerebrovascular reactivity is impaired in patients with cardiac failure
    • Georgiadis D, Sievert M, Cencetti S, et al. Cerebrovascular reactivity is impaired in patients with cardiac failure. Eur Heart J 2000; 21: 407-413.
    • (2000) Eur Heart J , vol.21 , pp. 407-413
    • Georgiadis, D.1    Sievert, M.2    Cencetti, S.3
  • 107
    • 15244348290 scopus 로고    scopus 로고
    • Localized cerebral blood flow reductions in patients with heart failure: a study using 99mTc-HMPAO SPECT
    • Alves TC, Rays J, Fraguas R Jr., et al. Localized cerebral blood flow reductions in patients with heart failure: a study using 99mTc-HMPAO SPECT. J Neuroimaging 2005; 15: 150-156.
    • (2005) J Neuroimaging , vol.15 , pp. 150-156
    • Alves, T.C.1    Rays, J.2    Fraguas Jr., R.3
  • 108
    • 33745939214 scopus 로고    scopus 로고
    • Left ventricular systolic dysfunction and the risk of ischemic stroke in a multiethnic population
    • Hays AG, Sacco RL, Rundek T, et al. Left ventricular systolic dysfunction and the risk of ischemic stroke in a multiethnic population. Stroke 2006; 37: 1715-1719.
    • (2006) Stroke , vol.37 , pp. 1715-1719
    • Hays, A.G.1    Sacco, R.L.2    Rundek, T.3
  • 109
    • 0030894209 scopus 로고    scopus 로고
    • Ejection fraction and risk of thromboembolic events in patients with systolic dysfunction and sinus rhythm: evidence for gender differences in the studies of left ventricular dysfunction trials [Erratum appears in J Am Coll Cardiol 1998;32:555]
    • Dries DL, Rosenberg YD, Waclawiw MA, Domanski MJ. Ejection fraction and risk of thromboembolic events in patients with systolic dysfunction and sinus rhythm: evidence for gender differences in the studies of left ventricular dysfunction trials. [Erratum appears in J Am Coll Cardiol 1998; 32: 555]. J Am Coll Cardiol 1997; 29: 1074-1080.
    • (1997) J Am Coll Cardiol , vol.29 , pp. 1074-1080
    • Dries, D.L.1    Rosenberg, Y.D.2    Waclawiw, M.A.3    Domanski, M.J.4
  • 110
    • 0032520946 scopus 로고    scopus 로고
    • Anticoagulation in dilated cardiomyopathy
    • Koniaris LS, Goldhaber SZ. Anticoagulation in dilated cardiomyopathy. J Am Coll Cardiol 1998; 31: 745-748.
    • (1998) J Am Coll Cardiol , vol.31 , pp. 745-748
    • Koniaris, L.S.1    Goldhaber, S.Z.2
  • 111
    • 0027294783 scopus 로고
    • Incidence of thromboembolic events in congestive heart failure. The V-HeFT VA Cooperative Studies Group
    • Dunkman WB, Johnson GR, Carson PE, et al. Incidence of thromboembolic events in congestive heart failure. The V-HeFT VA Cooperative Studies Group. Circulation 1993; 87: VI94-101.
    • (1993) Circulation , vol.87 , pp. 94-101
    • Dunkman, W.B.1    Johnson, G.R.2    Carson, P.E.3
  • 112
    • 0022196910 scopus 로고
    • Prevention of arterial and pulmonary embolism by oral anticoagulants in patients with dilated cardiomyopathy
    • Kyrle PA, Korninger C, Gossinger H, et al. Prevention of arterial and pulmonary embolism by oral anticoagulants in patients with dilated cardiomyopathy. Thromb Haemost 1985; 54: 521-523.
    • (1985) Thromb Haemost , vol.54 , pp. 521-523
    • Kyrle, P.A.1    Korninger, C.2    Gossinger, H.3
  • 113
    • 2942535061 scopus 로고    scopus 로고
    • The Warfarin and Antiplatelet Therapy in Heart Failure trial (WATCH): rationale, design, and baseline patient characteristics
    • Massie BM, Krol WF, Ammon SE, et al. The Warfarin and Antiplatelet Therapy in Heart Failure trial (WATCH): rationale, design, and baseline patient characteristics. J Card Fail 2004; 10: 101-112.
    • (2004) J Card Fail , vol.10 , pp. 101-112
    • Massie, B.M.1    Krol, W.F.2    Ammon, S.E.3
  • 114
    • 65249116339 scopus 로고    scopus 로고
    • Randomized trial of warfarin, aspirin, and clopidogrel in patients with chronic heart failure: the Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) trial
    • Massie BM, Collins JF, Ammon SE, et al. Randomized trial of warfarin, aspirin, and clopidogrel in patients with chronic heart failure: the Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) trial. Circulation 2009; 119: 1616-1624.
    • (2009) Circulation , vol.119 , pp. 1616-1624
    • Massie, B.M.1    Collins, J.F.2    Ammon, S.E.3
  • 115
    • 33144465561 scopus 로고    scopus 로고
    • Warfarin versus aspirin in patients with reduced cardiac ejection fraction (WARCEF): rationale, objectives, and design
    • Pullicino P, Thompson JL, Barton B, et al. Warfarin versus aspirin in patients with reduced cardiac ejection fraction (WARCEF): rationale, objectives, and design. J Card Fail 2006; 12: 39-46.
    • (2006) J Card Fail , vol.12 , pp. 39-46
    • Pullicino, P.1    Thompson, J.L.2    Barton, B.3
  • 116
    • 34250836735 scopus 로고    scopus 로고
    • ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
    • (writing Committee to Revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons
    • Bonow RO, Carabello BA, Chatterjee K, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing Committee to Revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J Am Coll Cardiol 2006; 48: e1-e148.
    • (2006) J Am Coll Cardiol , vol.48
    • Bonow, R.O.1    Carabello, B.A.2    Chatterjee, K.3
  • 117
    • 0018180616 scopus 로고
    • The natural history of a non-stenotic bicuspid aortic valve
    • Mills P, Leech G, Davies M, Leathan A. The natural history of a non-stenotic bicuspid aortic valve. Br Heart J 1978; 40: 951-957.
    • (1978) Br Heart J , vol.40 , pp. 951-957
    • Mills, P.1    Leech, G.2    Davies, M.3    Leathan, A.4
  • 120
    • 0031760078 scopus 로고    scopus 로고
    • Antithrombotic therapy in patients with saphenous vein and internal mammary artery bypass grafts
    • Stein PD, Dalen JE, Goldman S, Theroux P. Antithrombotic therapy in patients with saphenous vein and internal mammary artery bypass grafts. Chest 1998; 114: 658S-665S.
    • (1998) Chest , vol.114 , pp. 658-665
    • Stein, P.D.1    Dalen, J.E.2    Goldman, S.3    Theroux, P.4
  • 121
    • 0023939364 scopus 로고
    • The risk for systemic embolization associated with percutaneous balloon valvuloplasty in adults. A prospective comprehensive evaluation
    • Davidson CJ, Skelton TN, Kisslo KB, et al. The risk for systemic embolization associated with percutaneous balloon valvuloplasty in adults. A prospective comprehensive evaluation. Ann Intern Med 1988; 108: 557-560.
    • (1988) Ann Intern Med , vol.108 , pp. 557-560
    • Davidson, C.J.1    Skelton, T.N.2    Kisslo, K.B.3
  • 122
    • 0028282497 scopus 로고
    • A population-based study of stroke in the setting of mitral valve prolapse: risk factors and infarct subtype classification
    • Petty GW, Orencia AJ, Khandheria BK, Whisnant JP. A population-based study of stroke in the setting of mitral valve prolapse: risk factors and infarct subtype classification. Mayo Clin Proc 1994; 69: 632-634.
    • (1994) Mayo Clin Proc , vol.69 , pp. 632-634
    • Petty, G.W.1    Orencia, A.J.2    Khandheria, B.K.3    Whisnant, J.P.4
  • 123
    • 0023195240 scopus 로고
    • Cerebral ischemia with mitral valve prolapse
    • Wolf PA, Sila CA. Cerebral ischemia with mitral valve prolapse. Am Heart J 1987; 113: 1308-1315.
    • (1987) Am Heart J , vol.113 , pp. 1308-1315
    • Wolf, P.A.1    Sila, C.A.2
  • 124
    • 0031789424 scopus 로고    scopus 로고
    • Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves
    • Stein PD, Alpert JS, Dalen JE, Horstkotte D, Turpie AG. Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves. Chest 1998; 114: 602S-610S.
    • (1998) Chest , vol.114 , pp. 602-610
    • Stein, P.D.1    Alpert, J.S.2    Dalen, J.E.3    Horstkotte, D.4    Turpie, A.G.5
  • 125
    • 0003360637 scopus 로고
    • Tumors of the Cardiovascular System
    • 1st ed. Washington, D. C.: Armed Forces Institute of Pathology
    • Landing BH, Farber S. Tumors of the Cardiovascular System. Atlas of Tumor Pathology, 1st ed. Washington, D. C.: Armed Forces Institute of Pathology; 1956.
    • (1956) Atlas of Tumor Pathology
    • Landing, B.H.1    Farber, S.2
  • 126
    • 0342502275 scopus 로고    scopus 로고
    • Frequency of primary tumors of the heart
    • Reynen K. Frequency of primary tumors of the heart. Am J Cardiol 1996; 77: 107.
    • (1996) Am J Cardiol , vol.77 , pp. 107
    • Reynen, K.1
  • 127
    • 35848960318 scopus 로고    scopus 로고
    • Lambl's excrescences: review and recommendations
    • Aziz F, Baciewicz FA, Jr. Lambl's excrescences: review and recommendations. Tex Heart Inst J 2007; 34: 366-368.
    • (2007) Tex Heart Inst J , vol.34 , pp. 366-368
    • Aziz, F.1    Baciewicz Jr., F.A.2
  • 128
    • 0019860719 scopus 로고
    • Management of infective endocarditis
    • Dismukes WE. Management of infective endocarditis. Cardiovasc Clin 1981; 11: 189-208.
    • (1981) Cardiovasc Clin , vol.11 , pp. 189-208
    • Dismukes, W.E.1
  • 129
    • 0023270332 scopus 로고
    • General principles of the treatment of infective endocarditis
    • Fleming HA. General principles of the treatment of infective endocarditis. J Antimicrob Chemother 1987; 20(suppl A): 143-145.
    • (1987) J Antimicrob Chemother , vol.20 , Issue.SUPPL. A , pp. 143-145
    • Fleming, H.A.1
  • 132
    • 0023519458 scopus 로고
    • Infective endocarditis: a pathophysiologic approach to therapy
    • Robbins MJ, Eisenberg ES, Frishman WH. Infective endocarditis: a pathophysiologic approach to therapy. Cardiol Clin 1987; 5: 545-562.
    • (1987) Cardiol Clin , vol.5 , pp. 545-562
    • Robbins, M.J.1    Eisenberg, E.S.2    Frishman, W.H.3
  • 134
    • 0029643775 scopus 로고
    • Cardiac myxomas
    • Reynen K. Cardiac myxomas. N Engl J Med 1995; 333: 1610-1617.
    • (1995) N Engl J Med , vol.333 , pp. 1610-1617
    • Reynen, K.1
  • 135
    • 28244472771 scopus 로고    scopus 로고
    • Clinical practice. Patent foramen ovale in young adults with unexplained stroke [Erratum appears in N Engl J Med 2006;354:2401]
    • Kizer JR, Devereux RB. Clinical practice. Patent foramen ovale in young adults with unexplained stroke. [Erratum appears in N Engl J Med 2006; 354: 2401]. N Engl J Med 2005; 353: 2361-2372.
    • (2005) N Engl J Med , vol.353 , pp. 2361-2372
    • Kizer, J.R.1    Devereux, R.B.2
  • 136
    • 0035857141 scopus 로고    scopus 로고
    • Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both
    • Mas JL, Arquizan C, Lamy C, et al. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med 2001; 345: 1740-1746.
    • (2001) N Engl J Med , vol.345 , pp. 1740-1746
    • Mas, J.L.1    Arquizan, C.2    Lamy, C.3
  • 138
    • 77956164483 scopus 로고    scopus 로고
    • Anticoagulation therapy for cardioembolic stroke prevention in the elderly: defining benefits and risks
    • Freeman WD, Aguilar M. Anticoagulation therapy for cardioembolic stroke prevention in the elderly: defining benefits and risks. Aging Health 2010; 6: 439-450.
    • (2010) Aging Health , vol.6 , pp. 439-450
    • Freeman, W.D.1    Aguilar, M.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.